Key result
Marfan syndrome cardiomyocytes exhibited significantly increased stiffness (p<0.0001), decreased contraction amplitude, and lower beat-to-beat variability compared to corrected cardiomyocytes.
Why the study?
Myocardial dysfunction occurs in Marfan syndrome patients and mouse models, but little is known about the intrinsic effect of FBN1 mutations on cardiomyocytes.
Answers are grounded in this paper and cite their sources.
This first in vitro cardiac cell culture model for Marfan syndrome demonstrates that fibrillin-1 mutations intrinsically alter cardiomyocyte behavior, leading to increased stiffness, reduced contraction, and impaired response to stress due to extracellular matrix defects.
Marfan syndrome (MFS) is a systemic disorder of connective tissue caused by pathogenic variants in the fibrillin-1 (FBN1) gene. Myocardial dysfunction has been demonstrated in MFS patients and mouse models, but little is known about the intrinsic effect on the cardiomyocytes (CMs). In this study, both induced pluripotent stem cells derived from a MFS-patient and the line with the corrected FBN1 mutation were differentiated to CMs. Several functional analyses are performed on this model to study MFS related cardiomyopathy. Atomic force microscopy revealed that MFS CMs are stiffer compared to corrected CMs. The contraction amplitude of MFS CMs is decreased compared to corrected CMs. Under normal culture conditions, MFS CMs show a lower beat-to-beat variability compared to corrected CMs using multi electrode array. Isoproterenol-induced stress or cyclic strain demonstrates lack of support from the matrix in MFS CMs. This study reports the first cardiac cell culture model for MFS, revealing abnormalities in the behavior of MFS CMs that are related to matrix defects. Based on these results, we postulate that impaired support from the extracellular environment plays a key role in the improper functioning of CMs in MFS.
No takes yet. Share an insight, caveat, or question.
Aalders et al. (2020) studied Marfan syndrome. FBN1 mutation vs. Isogenic CRISPR-Cas9 corrected cardiomyocytes was evaluated on Cardiomyocyte stiffness (Young's modulus), contraction amplitude, and beat-to-beat variability (p=<0.0001). Marfan syndrome cardiomyocytes exhibited significantly increased stiffness (p<0.0001), decreased contraction amplitude, and lower beat-to-beat variability compared to corrected cardiomyocytes.
Synapse has enriched 10 related papers. Consider them for comparative context: